Skip to content

Prospective evaluation of perioperative navigated transcranial magnetic stimulation (nTMS) for neurosurgical procedures

Prospective evaluation of perioperative navigated transcranial magnetic stimulation (nTMS) for neurosurgical procedures

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025173
Enrollment
60
Registered
2021-05-04
Start date
2021-06-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9 C79.3

Interventions

Group 1: Patients with brain tumors close to motoric eloquent areas receive a navigated transcranial megnetic stimulation (nTMS) examination prior to brain tumor surgery. After the nTMS-examination a

Sponsors

Klinik für Neurochirurgie Klinikum Nürnberg Paracelsus Medizinische Privatuniversität
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patient with brain tumors Gross total resection or subtotal resection is to achieve supratentorial tumor localisation tumor localisation close to functional motor area or patients symptomatic with motor deficits suspected tumor entity: primary or secondary brain tumor surgical treatment of every of the patient's tumorous lesions

Exclusion criteria

Exclusion criteria: no MRI possible (cochlea implant, cardiac pacemaker, other implants that do not allow MRI) CSF fluid diversion patients with deep brain stimulation devices, spinal cord stimulator or medication pumps patient refuses participation patient cannot consent patients who receive additional nrTMS language mapping pregnant or breastfeeding female patients patients with exclusively infratentorial lesions patients with suspected meningiomas as lesions that should be treated patients under dialysis patients with coronary heart disease (myocardial infarction or cardiac stents) patients with cardiac arrhythmia (first degree AV-block excluded) cardiac failure NYHA III and NYHA IV

Design outcomes

Primary

MeasureTime frame
Difference in tumor diameter (mm) preoperatively and postoperatively

Secondary

MeasureTime frame
Difference of tumor volume (cm³) preoperatively and postoperatively Postoperative neurological status (motor function MRC grade) Postoperative neurological status (NIHSS) prognostic value of nTMS for postoperative motor function prognostic value of nTMS-DTI fibertracking for postoperative motor function prognostic value of the distance to fiber tracts regarding residual tumor size improvement in nTMS-examination setting according to the answers of the patient questionnaire association between postoperative DTI-fibertracking and neurologic outcome

Countries

Germany

Contacts

Public ContactThomas Eibl

Klinik für Neurochirurgie Klinikum Nürnberg Paracelsus Medizinische Privatuniversität

thomas.eibl@klinikum-nuernberg.de+499113982318

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026